Mobilab is a multi-parameter, pocket-sized Point-of-Care-Testing (POCT) device that is envisioned to test 25 parameters related to diagnosis of chronic Non-Communicable Diseases (NCDs) of Kidney, Liver, Heart, and Pancreas
Indian Institute of Technology Guwahati alumni-led start-up, Primary Healthtech has developed an indigenous point-of-care-testing (POCT) device, Mobilab, that is expected to test 25 parameters in blood to diagnose early the chronic diseases related to kidney, liver, heart, and pancreas malfunctions.
The device is operated through an IoT-enabled Android app and can perform about 150 tests with a single charge of the battery, which enables a digitally connected ecosystem for its use even for the remotest locations of the nation and serves the last-mile population.
It has been supported by the Centre for Nanotechnology, IIT Guwahati; Ministry of Electronics and Information Technology, Govt of India; ICMR-Department of Health Research Centre of Excellence, Ministry of Social Justice and Empowerment, SIIC-IIT Kanpur, AIC-CCMB, KIIT-TBI, CPS- IITI, DBT-BIRAC, IIT Guwahati and Start-Up India. The mass production has been planned by establishing a vendor network at a cost that is affordable and at the same time sustainable.
The device is expected to perform the early screening of Non-Communicable Diseases (NCDs). Mobilab will enable testing at patients’ sites at a low cost to enable early screening as well as long-term disease management at an affordable cost for millions of people every year.
Mobilab is a multi-parameter, pocket-sized Point-of-Care-Testing (POCT) device that is envisioned to test 25 parameters related to diagnosis of chronic Non-Communicable Diseases (NCDs) of Kidney, Liver, Heart, and Pancreas
Mobilab is validated at various levels in hospitals such as Guwahati Medical College & Hospital – GMCH, Guwahati Neurological Research Centre – GNRC, Nemcare, Army Hospital, AIIMS New Delhi, and has been deployed in various parts of Assam, Maharashtra, Uttar Pradesh, Madhya Pradesh, Gujrat, Delhi, and Arunachal Pradesh.
Speaking about Mobilab, Sahil Jagnani, Alumnus, IIT Guwahati, and Founder & CEO, Primary Healthtech, said, “The vision of Mobilab is to make diagnosis available to fellow citizens at an affordable cost, along with generating instant results to speed up the early screening, disease management, and treatment. Mobilab is also expected to perform import substitution under the Make-in-India initiative of the Government of India.”